Hemorrhagic type Moyamoya disease

被引:0
|
作者
Saeki, N [1 ]
Nakazaki, S [1 ]
Kubota, M [1 ]
Yamaura, A [1 ]
Hoshi, S [1 ]
Sunada, S [1 ]
Sunami, K [1 ]
机构
[1] KAWATETSU CHIBA HOSP,DEPT NEUROL SURG,CHIBA,JAPAN
关键词
Moyamoya disease; hemorrhage; intraventricular hemorrhage; magnetic resonance imaging; bypass surgery;
D O I
暂无
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
The clinical picture of hemorrhagic type Moyamoya disease was analyzed in 20 cases. Hematoma at the basal ganglia was noted in 40% of cases, intraventricular hemorrhage (IVH) in 30%, thalamic hemorrhage with ventricular rupture in 15% and subcortical hemorrhage in 5%. The location was undetermined in two cases (10%) due to bleeding in the pre-computed tomography (CT) era. The frequencies shown above were correlated well to previous reports. In magnetic resonance imaging (MRI) performed 1 year or more after IVH, the primary bleeding site was demonstrated at the lateral wall of lateral ventricle, in proton density weighted and T-2 weighted images. MRI can detect the site of old bleeding points and its chronological change if the study is repeated. In a follow-up period of 6.2 years, 35% of the cases had rebleeding once or twice. The second bleeding occured seven times and the third twice. IVH occurred five times and the most common, basal ganglia hematoma three times while thalamic hemorrhage once. As a result, the rate of good outcome was 60% after the first bleeding and 40% after rebleedings. The mortality rate was 5% after the first and 25% after rebleedings. Factors related to rebleedings and their poorer outcome are sex (with women being more susceptible), massive ICH and early recurrence. Rebleedings worsened the outcome. Therefore, prevention of rebleeding is important, From a therapeutic viewpoint, although a close relation between rebleeding and untreated hypertension could not be established, blood pressure control is critical at the both acute and chronic stages. Bypass surgery for bleeding type of Moyamoya disease seems to be less promising than ischemic type, even though a definite answer may not be obtained from our small number of cases. (C) 1997 Elsevier Science B.V.
引用
收藏
页码:S196 / S201
页数:6
相关论文
共 50 条
  • [31] Significance of Cyclooxygenase-2 Elevation in Middle Cerebral Artery for Patients with Hemorrhagic Moyamoya Disease
    Zhang, Jian-jian
    Xiong, Zhong-wei
    Wang, Sheng
    Sun, Shou-jia
    Wang, Hao
    Wu, Xiao-lin
    Wang, Long
    Zhang, Hua-qiu
    You, Chao
    Wang, Yu
    Chen, Jin-Cao
    JOURNAL OF HUAZHONG UNIVERSITY OF SCIENCE AND TECHNOLOGY-MEDICAL SCIENCES, 2016, 36 (02) : 181 - 185
  • [32] Significance of cyclooxygenase-2 elevation in middle cerebral artery for patients with hemorrhagic moyamoya disease
    Jian-jian Zhang
    Zhong-wei Xiong
    Sheng Wang
    Shou-jia Sun
    Hao Wang
    Xiao-lin Wu
    Long Wang
    Hua-qiu Zhang
    Chao You
    Yu Wang
    Jin-cao Chen
    Journal of Huazhong University of Science and Technology [Medical Sciences], 2016, 36 : 181 - 185
  • [33] Assessment of cognitive function in adult patients with hemorrhagic moyamoya disease who received no surgical revascularization
    Su, S. -H.
    Hai, J.
    Zhang, L.
    Yu, F.
    Wu, Y. -F.
    EUROPEAN JOURNAL OF NEUROLOGY, 2013, 20 (07) : 1081 - 1087
  • [34] Clinical and Genetic Characteristics of Patients with Moyamoya Disease who Experienced Both Ischemic and Hemorrhagic Events
    Hirano, Yudai
    Miyawaki, Satoru
    Imai, Hideaki
    Hongo, Hiroki
    Teranishi, Yu
    Ishigami, Daiichiro
    Sakai, Yu
    Shimada, Daisuke
    Umekawa, Motoyuki
    Segawa, Masafumi
    Koizumi, Satoshi
    Ono, Hideaki
    Nakatomi, Hirofumi
    Saito, Nobuhito
    WORLD NEUROSURGERY, 2023, 172 : E438 - E446
  • [35] Moyamoya disease
    Fukui, M
    Kono, S
    Sueishi, K
    Ikezaki, K
    NEUROPATHOLOGY, 2000, 20 : S61 - S64
  • [36] Neuro-endoscopic management of hemorrhagic moyamoya disease in the acute stage: single institute experience
    Mino, Masaki
    Fujimura, Miki
    Endo, Hidenori
    Endo, Toshiki
    Sato, Kenichi
    Tominaga, Teiji
    NEUROLOGICAL RESEARCH, 2019, 41 (12) : 1097 - 1103
  • [37] Significance of Cyclooxygenase-2 Elevation in Middle Cerebral Artery for Patients with Hemorrhagic Moyamoya Disease
    章剑剑
    熊忠伟
    王胜
    孙守家
    王昊
    吴小林
    王龙
    张华楸
    游超
    王煜
    陈劲草
    Current Medical Science, 2016, (02) : 181 - 185
  • [38] MMP-9 as a Biomarker for Predicting Hemorrhagic Strokes in Moyamoya Disease
    Lu, Junlin
    Wang, Jingyi
    Lin, Zhidong
    Shi, Guangchao
    Wang, Rong
    Zhao, Yahui
    Zhao, Yuanli
    Zhao, Jizong
    FRONTIERS IN NEUROLOGY, 2021, 12
  • [39] Recurrent Bleeding in Hemorrhagic Moyamoya Disease : Prognostic Implications of the Perfusion Status
    Jo, Kyung-Il
    Kim, Min Soo
    Yeon, Je Young
    Kim, Jong-Soo
    Hong, Seung-Chyul
    JOURNAL OF KOREAN NEUROSURGICAL SOCIETY, 2016, 59 (02) : 117 - 121
  • [40] Moyamoya Disease: Recent Progress and Outlook
    Takahashi, Jun C.
    Miyamoto, Susumu
    NEUROLOGIA MEDICO-CHIRURGICA, 2010, 50 (09) : 824 - 832